Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.
Identifieur interne : 000402 ( PubMed/Curation ); précédent : 000401; suivant : 000403Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.
Auteurs : Raj P. Pal [Royaume-Uni] ; Masood A. KhanSource :
- Urologia internationalis [ 1423-0399 ] ; 2012.
Descripteurs français
- KwdFr :
- Adénocarcinome (), Adénocarcinome (anatomopathologie), Angleterre, Complications postopératoires (étiologie), Conception d'appareillage, Facteurs temps, Humains, Hyperplasie de la prostate (), Hyperplasie de la prostate (anatomopathologie), Hôpitaux d'enseignement, Lasers à solide, Miction, Mâle, Obstruction du col de la vessie (), Obstruction du col de la vessie (physiopathologie), Obstruction du col de la vessie (étiologie), Prostate (), Prostate (anatomopathologie), Récupération fonctionnelle, Résultat thérapeutique, Thulium, Thérapie laser (effets indésirables), Thérapie laser (instrumentation), Tumeurs de la prostate (), Tumeurs de la prostate (anatomopathologie), Urodynamique.
- MESH :
- anatomopathologie : Adénocarcinome, Hyperplasie de la prostate, Prostate, Tumeurs de la prostate.
- effets indésirables : Thérapie laser.
- physiopathologie : Obstruction du col de la vessie.
- étiologie : Complications postopératoires, Obstruction du col de la vessie, Thérapie laser.
- Adénocarcinome, Angleterre, Conception d'appareillage, Facteurs temps, Humains, Hyperplasie de la prostate, Hôpitaux d'enseignement, Lasers à solide, Miction, Mâle, Obstruction du col de la vessie, Prostate, Récupération fonctionnelle, Résultat thérapeutique, Thulium, Tumeurs de la prostate, Urodynamique.
English descriptors
- KwdEn :
- Adenocarcinoma (complications), Adenocarcinoma (pathology), Adenocarcinoma (surgery), England, Equipment Design, Hospitals, Teaching, Humans, Laser Therapy (adverse effects), Laser Therapy (instrumentation), Lasers, Solid-State, Male, Postoperative Complications (etiology), Prostate (pathology), Prostate (surgery), Prostatic Hyperplasia (complications), Prostatic Hyperplasia (pathology), Prostatic Hyperplasia (surgery), Prostatic Neoplasms (complications), Prostatic Neoplasms (pathology), Prostatic Neoplasms (surgery), Recovery of Function, Thulium, Time Factors, Treatment Outcome, Urinary Bladder Neck Obstruction (etiology), Urinary Bladder Neck Obstruction (physiopathology), Urinary Bladder Neck Obstruction (surgery), Urination, Urodynamics.
- MESH :
- chemical : Thulium.
- geographic : England.
- adverse effects : Laser Therapy.
- complications : Adenocarcinoma, Prostatic Hyperplasia, Prostatic Neoplasms.
- etiology : Postoperative Complications, Urinary Bladder Neck Obstruction.
- instrumentation : Laser Therapy.
- pathology : Adenocarcinoma, Prostate, Prostatic Hyperplasia, Prostatic Neoplasms.
- physiopathology : Urinary Bladder Neck Obstruction.
- surgery : Adenocarcinoma, Prostate, Prostatic Hyperplasia, Prostatic Neoplasms, Urinary Bladder Neck Obstruction.
- Equipment Design, Hospitals, Teaching, Humans, Lasers, Solid-State, Male, Recovery of Function, Time Factors, Treatment Outcome, Urination, Urodynamics.
Abstract
To assess the safety and clinical efficacy of Tm:YAG laser vaporesection of the prostate (ThuVaRP) at intermediate-term follow-up.
DOI: 10.1159/000330901
PubMed: 22133639
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000402
Links to Exploration step
pubmed:22133639Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.</title>
<author><name sortKey="Pal, Raj P" sort="Pal, Raj P" uniqKey="Pal R" first="Raj P" last="Pal">Raj P. Pal</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Urology, University Hospitals of Leicester, Clinical Sciences Unit, Leicester General Hospital, Leicester, UK. rppal @ doctors.org.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, University Hospitals of Leicester, Clinical Sciences Unit, Leicester General Hospital, Leicester</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Khan, Masood A" sort="Khan, Masood A" uniqKey="Khan M" first="Masood A" last="Khan">Masood A. Khan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2012">2012</date>
<idno type="doi">10.1159/000330901</idno>
<idno type="RBID">pubmed:22133639</idno>
<idno type="pmid">22133639</idno>
<idno type="wicri:Area/PubMed/Corpus">000402</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000402</idno>
<idno type="wicri:Area/PubMed/Curation">000402</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000402</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.</title>
<author><name sortKey="Pal, Raj P" sort="Pal, Raj P" uniqKey="Pal R" first="Raj P" last="Pal">Raj P. Pal</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Urology, University Hospitals of Leicester, Clinical Sciences Unit, Leicester General Hospital, Leicester, UK. rppal @ doctors.org.uk</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Urology, University Hospitals of Leicester, Clinical Sciences Unit, Leicester General Hospital, Leicester</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Khan, Masood A" sort="Khan, Masood A" uniqKey="Khan M" first="Masood A" last="Khan">Masood A. Khan</name>
</author>
</analytic>
<series><title level="j">Urologia internationalis</title>
<idno type="eISSN">1423-0399</idno>
<imprint><date when="2012" type="published">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (complications)</term>
<term>Adenocarcinoma (pathology)</term>
<term>Adenocarcinoma (surgery)</term>
<term>England</term>
<term>Equipment Design</term>
<term>Hospitals, Teaching</term>
<term>Humans</term>
<term>Laser Therapy (adverse effects)</term>
<term>Laser Therapy (instrumentation)</term>
<term>Lasers, Solid-State</term>
<term>Male</term>
<term>Postoperative Complications (etiology)</term>
<term>Prostate (pathology)</term>
<term>Prostate (surgery)</term>
<term>Prostatic Hyperplasia (complications)</term>
<term>Prostatic Hyperplasia (pathology)</term>
<term>Prostatic Hyperplasia (surgery)</term>
<term>Prostatic Neoplasms (complications)</term>
<term>Prostatic Neoplasms (pathology)</term>
<term>Prostatic Neoplasms (surgery)</term>
<term>Recovery of Function</term>
<term>Thulium</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Urinary Bladder Neck Obstruction (etiology)</term>
<term>Urinary Bladder Neck Obstruction (physiopathology)</term>
<term>Urinary Bladder Neck Obstruction (surgery)</term>
<term>Urination</term>
<term>Urodynamics</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adénocarcinome ()</term>
<term>Adénocarcinome (anatomopathologie)</term>
<term>Angleterre</term>
<term>Complications postopératoires (étiologie)</term>
<term>Conception d'appareillage</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Hyperplasie de la prostate ()</term>
<term>Hyperplasie de la prostate (anatomopathologie)</term>
<term>Hôpitaux d'enseignement</term>
<term>Lasers à solide</term>
<term>Miction</term>
<term>Mâle</term>
<term>Obstruction du col de la vessie ()</term>
<term>Obstruction du col de la vessie (physiopathologie)</term>
<term>Obstruction du col de la vessie (étiologie)</term>
<term>Prostate ()</term>
<term>Prostate (anatomopathologie)</term>
<term>Récupération fonctionnelle</term>
<term>Résultat thérapeutique</term>
<term>Thulium</term>
<term>Thérapie laser (effets indésirables)</term>
<term>Thérapie laser (instrumentation)</term>
<term>Tumeurs de la prostate ()</term>
<term>Tumeurs de la prostate (anatomopathologie)</term>
<term>Urodynamique</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Thulium</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>England</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Laser Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Hyperplasie de la prostate</term>
<term>Prostate</term>
<term>Tumeurs de la prostate</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Adenocarcinoma</term>
<term>Prostatic Hyperplasia</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Thérapie laser</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Postoperative Complications</term>
<term>Urinary Bladder Neck Obstruction</term>
</keywords>
<keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Laser Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Prostate</term>
<term>Prostatic Hyperplasia</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Obstruction du col de la vessie</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Urinary Bladder Neck Obstruction</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term>
<term>Prostate</term>
<term>Prostatic Hyperplasia</term>
<term>Prostatic Neoplasms</term>
<term>Urinary Bladder Neck Obstruction</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Obstruction du col de la vessie</term>
<term>Thérapie laser</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Equipment Design</term>
<term>Hospitals, Teaching</term>
<term>Humans</term>
<term>Lasers, Solid-State</term>
<term>Male</term>
<term>Recovery of Function</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
<term>Urination</term>
<term>Urodynamics</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adénocarcinome</term>
<term>Angleterre</term>
<term>Conception d'appareillage</term>
<term>Facteurs temps</term>
<term>Humains</term>
<term>Hyperplasie de la prostate</term>
<term>Hôpitaux d'enseignement</term>
<term>Lasers à solide</term>
<term>Miction</term>
<term>Mâle</term>
<term>Obstruction du col de la vessie</term>
<term>Prostate</term>
<term>Récupération fonctionnelle</term>
<term>Résultat thérapeutique</term>
<term>Thulium</term>
<term>Tumeurs de la prostate</term>
<term>Urodynamique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To assess the safety and clinical efficacy of Tm:YAG laser vaporesection of the prostate (ThuVaRP) at intermediate-term follow-up.</div>
</front>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">22133639</PMID>
<DateCreated><Year>2012</Year>
<Month>01</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>06</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1423-0399</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>88</Volume>
<Issue>1</Issue>
<PubDate><Year>2012</Year>
</PubDate>
</JournalIssue>
<Title>Urologia internationalis</Title>
<ISOAbbreviation>Urol. Int.</ISOAbbreviation>
</Journal>
<ArticleTitle>Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital.</ArticleTitle>
<Pagination><MedlinePgn>39-42</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1159/000330901</ELocationID>
<Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To assess the safety and clinical efficacy of Tm:YAG laser vaporesection of the prostate (ThuVaRP) at intermediate-term follow-up.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">We identified the first 60 consecutive patients who underwent ThuVaRP at our institute. Operative outcomes assessed were resection time, resection weight, drop in haemoglobin, transfusion rate, catheter time and complication rate. The International Prostate Symptom Score (IPSS) was documented at a mean follow-up period of 19 months postoperatively.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">45/60 patients underwent treatment due to lower urinary tract symptoms secondary to benign prostatic obstruction, 11/60 patients had a long-term catheter in situ for refractory urinary retention secondary to benign prostatic obstruction, and 4/60 patients had bladder outflow obstruction secondary to adenocarcinoma of the prostate. 1/60 patients developed urosepsis, 1/60 patients developed a urinary tract infection and 1/60 patients required 3-way catheterization and irrigation due to haematuria. No patients required a blood transfusion. The mean IPSS at a mean follow-up interval of 19 months (range 15-28 months) was 5.1 (range 1-23). Postoperative maximum flow rate improved from 7.9 to 17.1 ml/s, and post-micturition residual volume decreased from 254 to 86 ml.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ThuVaRP is safe and appears to have durable efficacy at intermediate follow-up.</AbstractText>
<CopyrightInformation>Copyright © 2011 S. Karger AG, Basel.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pal</LastName>
<ForeName>Raj P</ForeName>
<Initials>RP</Initials>
<AffiliationInfo><Affiliation>Department of Urology, University Hospitals of Leicester, Clinical Sciences Unit, Leicester General Hospital, Leicester, UK. rppal @ doctors.org.uk</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Khan</LastName>
<ForeName>Masood A</ForeName>
<Initials>MA</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>11</Month>
<Day>29</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Urol Int</MedlineTA>
<NlmUniqueID>0417373</NlmUniqueID>
<ISSNLinking>0042-1138</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber>
<NameOfSubstance UI="D013932">Thulium</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000230">Adenocarcinoma</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" Type="Geographic" UI="D004739">England</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004867">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006784">Hospitals, Teaching</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D053685">Laser Therapy</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000295">instrumentation</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D053844">Lasers, Solid-State</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011467">Prostate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D011471">Prostatic Neoplasms</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D020127">Recovery of Function</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="Y" UI="D013932">Thulium</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D001748">Urinary Bladder Neck Obstruction</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000503">physiopathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014554">Urination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D014563">Urodynamics</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year>
<Month>2</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2011</Year>
<Month>6</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint"><Year>2011</Year>
<Month>11</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>6</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pii">000330901</ArticleId>
<ArticleId IdType="doi">10.1159/000330901</ArticleId>
<ArticleId IdType="pubmed">22133639</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000402 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000402 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= ThuliumV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:22133639 |texte= Intermediate-term efficacy of Tm:YAG laser prostate vaporesection for bladder outlet obstruction: initial experience from a UK teaching hospital. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:22133639" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ThuliumV1
This area was generated with Dilib version V0.6.21. |